JCB logo
Keystone Symposia
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
Published 9 June 2003. doi:10.1083/jcb.200211021
This Article
Right arrow Full Text
Right arrow PDF (Full Text)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rajan, P.
Right arrow Articles by McKay, R. D.G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rajan, P.
Right arrow Articles by McKay, R. D.G.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Stem Cells
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© The Rockefeller University Press, 0021-9525/2003/6/911 $5.00
The Journal of Cell Biology, Volume 161, Number 5, 911-921

Article

 BMPs signal alternately through a SMAD or FRAP–STAT pathway to regulate fate choice in CNS stem cells

Prithi Rajan, David M. Panchision, Laura F. Newell and Ronald D.G. McKay

Laboratory of Molecular Biology, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892

Address correspondence to Ronald D.G. McKay, 36 Convent Drive, MSC 4092, Bethesda, MD 20892. Tel.: (301) 496-6574. Fax: (301) 402-1340. E-mail: mckay{at}codon.nih.gov

The ability of stem cells to generate distinct fates is critical for the generation of cellular diversity during development. Central nervous system (CNS) stem cells respond to bone morphogenetic protein (BMP) 4 by differentiating into a wide variety of dorsal CNS and neural crest cell types. We show that distinct mechanisms are responsible for the generation of two of these cell types, smooth muscle and glia. Smooth muscle differentiation requires BMP-mediated Smad1/5/8 activation and predominates where local cell density is low. In contrast, glial differentiation predominates at high local densities in response to BMP4 and is specifically blocked by a dominant-negative mutant Stat3. Upon BMP4 treatment, the serine-threonine kinase FKBP12/rapamycin-associated protein (FRAP), mammalian target of rapamycin (mTOR), associates with Stat3 and facilitates STAT activation. Inhibition of FRAP prevents STAT activation and glial differentiation. Thus, glial differentiation by BMP4 occurs by a novel pathway mediated by FRAP and STAT proteins. These results suggest that a single ligand can regulate cell fate by activating distinct cytoplasmic signals.

Key Words: bone morphogenetic protein; stem cell; SMAD; STAT; mammalian FRAP

P. Rajan and D.M. Panchision contributed equally to this work.

P. Rajan's present address is Psychiatric Genomics, Inc., 19 Firstfield Road, Gaithersburg, MD 20878.

* Abbreviations used in this paper: bFGF, basic FGF; BMP, bone morphogenetic protein; BMPR-IA, BMP receptor type one A; CNS, central nervous system; CNTF, ciliary neurotrophic factor; EMSA, electrophoretic mobility shift assay; FRAP, FKBP12/rapamycin-associated protein; FRB, FKBP12-rapamycin binding; GFAP, glial fibrillary acidic protein; SMA, smooth muscle {alpha}-actin.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents